C

Cogent Biosciences

Develops small-molecule therapies for rare diseases

Manager – Communications and Investor Relations

PR & CommunicationsConfirmed live in the last 24 hours
Full-timeWaltham, MA, USAIn-person

About the Job

Requirements

  • A minimum of a Bachelor's degree in Communications, Journalism, Public Relations, Life Sciences, Marketing, or a related field.
  • A minimum of 5 years of experience at a publicly traded biotechnology or biopharmaceutical company in corporate communications, investor relations, science communications, or healthcare public relations; agency and/or in-house experience is welcome.
  • Exceptional writing and editing skills across press releases, social media content, briefing documents, executive messaging, website copy, and presentations, including experience working with legal and medical/regulatory review processes for external communications content.
  • Ability to take direction, work independently on execution, coordinate cross-functional workflows, and manage competing deadlines.
  • Hands-on experience executing corporate social media programs, including content drafting, calendar management, Reg FD principles, and cross-functional content coordination.
  • Working knowledge of the clinical development process and familiarity with how pipeline milestones, data readouts, and commercial launches drive communications activity.
  • Experience supporting communications around medical conferences such as AAAAI, ASH, ASCO, ESMO, or equivalent.
  • Strong organizational skills and attention to detail, including the ability to manage multiple concurrent workstreams, track and meet deadlines, and proactively identify and resolve issues.
  • Proficiency in Microsoft Office PowerPoint and Excel.
  • Experience with investor-relations analytics platforms such as Nasdaq IR Insight, FactSet/Irwin, and AlphaSense.

Responsibilities

  • Partner with the Head of Investor Relations to develop and maintain the company's core messaging framework, ensuring consistency across external materials and internal stakeholders.
  • Assist in creating and maintaining a corporate calendar across functions.
  • Assist in drafting press releases for corporate announcements, including clinical data, regulatory updates, milestones, partnerships, and executive news, for review by the Head of Investor Relations and legal team.
  • Maintain a library of clinical data communications precedents, peer-company disclosure benchmarks, and key-message archives.
  • Support internal communications with direction from the People Team.
  • Execute the company's day-to-day social media presence across LinkedIn and other relevant platforms, including drafting posts, maintaining the content calendar, and scheduling content.
  • Monitor social media channels for relevant activity, competitive posts, and emerging conversations, and prepare periodic reports.
  • Coordinate logistics and support preparation of materials and details for investor-relations activities, including earnings reporting through conference calls and webcasts, bus tours, and healthcare conferences.
  • Support digital investor-relations strategy, including maintaining the investor-relations website, investor-facing social media channels, and accuracy of online financial data.
  • Coordinate investor inquiries and maintain investor contact databases and other investor-relations records.

About the Company

Cogent Biosciences

Develops small-molecule therapies for rare diseases

Cogent Biosciences develops small molecule therapies for rare, genetically driven diseases. Its work centers on discovering and advancing compounds that can address conditions with limited treatment options, using a research-driven approach to guide drug discovery and development through clinical trials. The lead candidate, CGT9486, is progressing in three clinical trials planned for this year, alongside ongoing work in collaboration with partners. The company differentiates itself through its focus on genetically defined diseases, its emphasis on targeted small molecules, and its strategy of advancing candidates via internal science and partnerships, supported by a strong financial position that includes a cash reserve of $242.2 million. Cogent’s goal is to bring effective therapies to patients with unmet needs by progressing its drug candidates toward potential commercialization and forming strategic collaborations to maximize development and access.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Cogent Biosciences

See more jobs